Home/News/biopharmaceuticals
biopharmaceuticalsAI-assisted

CDMO Live Americas 2026 brings the Biopharma Outsourcing Community

CDMO Live Americas 2026 connects pharma, biotech and CDMO leaders in Boston for strategic partnerships, external manufacturing, drug development and CMC discussions.

Team Pharma Now
By Team Pharma Now
Publisher
Sep 01, 20263 min read
Share
CDMO Live Americas 2026  brings the Biopharma Outsourcing Community
AI-assisted reporting
Reviewed by Team Pharma Now, Publisher

CDMO Live, winner of Best Event Launch at the 2026 AEO Excellence Awards, will bring

together leaders from across pharmaceutical development, manufacturing, and outsourcing for

two days of focused partnering, networking, and industry discussion in Boston's Back Bay.

CDMO Live Americas is expected to draw more than 350 senior attendees, facilitate over

1,200 pre-scheduled meetings, and bring together 60+ CDMO partners.

In an increasingly uncertain world, outsourcing development and manufacturing is central to

delivering innovative therapies and supply to patients. With around 90% of biotechs relying on

CDMO networks, and commercial manufacturing demand rising fast, the relationships behind

those networks matter more than ever. CDMO Live Americas is where those external

manufacturing partnerships are made.

The event is designed for professionals responsible for external development and

manufacturing who are looking to identify the right partners, connect with industry peers, and

share insights for how to build more resilient outsourcing strategies.

Attendees will include leaders from across pharma and biotech, including representatives from

Johnson & Johnson, Takeda, Eli Lilly, Astellas, Bristol Myers Squibb, Vertex, Pfizer, and

AstraZeneca, alongside a wide range of partners spanning the outsourcing ecosystem.

At the heart of the event is PartnerMatch, a curated partnering program that connects

attendees with relevant development and manufacturing partners ahead of time. Rather than

leaving connections to chance, PartnerMatch helps ensure the right people find each other and

have conversations that can move potential partnerships forward - delegates arrive with a

personalized meeting agenda built around their own projects.

The agenda runs across two tracks — External Manufacturing Strategy and Drug

Development and CMC — combining benchmarking research, network strategy insights, and

interactive peer-to-peer roundtables covering everything from RFx to tech transfer.

Beyond the meeting room, the event's welcome reception, live music, and Waterfront Run along

Boston Harbor are designed to build the senior-level relationships that outlast the two days

themselves.

Past attendees have consistently pointed to the quality of the connections made at the event:

"CDMO Live is a key event for connecting with peers across the pharma industry. The

event is the perfect platform to exchange ideas and build strong partnerships."

Maik Talarczyk, Director ESO, Sandoz

"CDMO Live is a truly valuable experience. The quality of discussions, networking

opportunities, and overall organization is outstanding."

Melanie Wamsler, Network Strategy Director, Takeda

"Our CRDMO strategic partnership ecosystem is being built using the many relationships

we made at CDMO Live. It's an amazing experience, curated with intention — you build

exactly what you need there. I met many people in such a short time with interest in

supporting our mission, and got far more value than I'd imagined."

Fal Vaidya, CMC SSP & External Partnerships Senior Director, Gates Medical Research

Institute

Readers can receive 20% off their ticket to CDMO Live Americas 2026 using the exclusive

discount code LSR20 when booking.

Event: CDMO Live Americas 2026

Dates: October 20–21, 2026

Location: Sheraton Copley Place, Back Bay, 39 Dalton St, Boston, MA 02199, United States

Discount Code: LSR20

Team Pharma Now
Written by
Team Pharma Now
Publisher

Reporting on the science, business and regulation shaping the pharmaceutical industry.

Discussion

Loading discussion…

More from Pharma News

All stories →